/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Sacubitril/valsartan and quality of life assessed using the EQ-5D-3L questionnaire level sum score (LSS) in patients with heart failure across the spectrum of ejection fraction
Event: Heart Failure 2025
Topic: Epidemiology, Prognosis, Outcome
Session: Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
Assessment of quality of life using EuroQol 5-Dimension questionnaire level sum score in patients with HFrEF, HFmrEF, and HFpEF: a patient-level meta-analysis of DAPA-HF and DELIVER
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Ejection fraction in heart failure: epidemiology, comorbidity, and quality of life
Sex-related differences in health-related quality-of-life measured using the EuroQol 5-Dimension questionnaire across the LVEF spectrum in DAPA-HF and DELIVER
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Deeper phenotyping in heart failure: race- and sex-related differences
